Merck Sharp & Dohme has won an injunction in Australia preventing generic rival Apotex from selling a range of nasal sprays alleged to infringe the IP rights in Merck’s Nasonex product The order comes ...
Credit: Getty Images. This is the first OTC formulation for Nasonex and is expected to be available later this year. The Food and Drug Administration (FDA) has approved the prescription to ...
Standing in the drugstore aisle confused? We've got you covered. From daily pills to nasal sprays, allergists break down ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results